STOCK TITAN

Aimei Health Technology (NASDAQ: AFJK) funds SPAC extension with $34K note

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd deposited $34,330.96 into its trust account for public shareholders, equal to the lesser of $80,000 in total or $0.033 per outstanding public share for a monthly extension. This extends the deadline to consummate its initial business combination from August 6, 2026 to September 6, 2026, representing the company’s 21st permitted extension.

To fund this payment, Aimei Health issued an unsecured, non‑interest‑bearing promissory note for $34,330.96 to Aimei Health Ltd, due upon completion of its business combination with United Hydrogen. The payee may convert the note into private units at $10.00 per unit, each unit including one ordinary share and a right to receive one‑fifth of an ordinary share, by giving written notice at least two business days before closing.

Positive

  • None.

Negative

  • None.

Filing Explained

The August 6 filing reports a one-month extension to September 6 and a related $34,330.96 note tied to completing the United Hydrogen business combination. However, the supplied July 8 company record reports that agreement’s termination, so the filing does not reconcile the stated transaction path with the company’s recorded status.

Sources and calculations
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Extension Payment $34,330.96 Deposited into the trust account for public shareholders for one-month extension
Per-share monthly extension amount $0.033 per outstanding public share Cap used to calculate each monthly extension payment
Maximum monthly extension cap $80,000 Alternative cap for all outstanding public shares for each monthly extension
Number of extensions used 21st extension The extension from August 6, 2026 to September 6, 2026
Promissory note principal $34,330.96 Unsecured, non‑interest‑bearing note issued to Aimei Health Ltd
Conversion price per private unit $10.00 per unit Price at which the promissory note may be converted into private units
Right per private unit One-fifth (1/5) of one ordinary share Each private unit includes a right to receive this fraction of an ordinary share
trust account financial
"deposited into the trust account of Aimei Health Technology Co., Ltd"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
Termination Date regulatory
"extend the period of time it has to consummate its initial business combination by one month ... to September 6, 2026 (the “Termination Date”)"
Termination date is the specific calendar day when a contract, agreement, option or other legal arrangement stops being in effect and any remaining rights or obligations expire. For investors it matters because that date sets deadlines for exercising rights, receiving payments, closing positions or avoiding penalties—similar to the day a lease or warranty ends, after which parties no longer have the same protections or claims.
Promissory Note financial
"issued, on August 6, 2026, an unsecured promissory note in the total principal amount"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
private units financial
"convert the Promissory Note, in whole or in part, into private units of the Company"
business combination financial
"period of time it has to consummate its initial business combination by one month"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What deadline extension did Aimei Health Technology (AFJK) obtain for its business combination?

Aimei Health Technology extended its business combination deadline by one month, moving the Termination Date from August 6, 2026 to September 6, 2026. This is the 21st extension permitted under its Amended and Restated Articles of Association.

How much did Aimei Health Technology (AFJK) deposit into the trust account for the latest extension?

Aimei Health Technology deposited $34,330.96 into its trust account for public shareholders. This Extension Payment equals the lesser of $80,000 for all outstanding public shares or $0.033 per outstanding public share for each monthly extension.

What are the key terms of the Aimei Health Technology (AFJK) promissory note?

The company issued an unsecured, non‑interest‑bearing promissory note for $34,330.96 to Aimei Health Ltd. The principal is payable when Aimei Health completes its business combination with United Hydrogen, and the note was used to fund the Extension Payment.

Can the Aimei Health Technology (AFJK) promissory note be converted into equity, and on what terms?

The payee may convert the note, in whole or part, into private units at $10.00 per unit. Each unit includes one ordinary share and a right to receive one‑fifth of an ordinary share, if notice is given at least two business days before closing.

Who is the payee on Aimei Health Technology (AFJK)’s promissory note for the extension payment?

The payee is Aimei Health Ltd, a Cayman Islands exempted company. It received the unsecured promissory note for $34,330.96, funding the trust account Extension Payment tied to Aimei Health Technology’s planned business combination with United Hydrogen.
false 0001979005 0001979005 2026-08-06 2026-08-06 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-08-06 2026-08-06 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-08-06 2026-08-06 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-08-06 2026-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

August 6, 2026

Date of Report (Date of earliest event reported)

 

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   001-41880   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

10 East 53rd Street, Suite 3001

New York, NY

  10022
(Address of Principal Executive Offices)   (Zip Code)

 

86-13758131392

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share   AFJK   The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share   AFJKR   The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right   AFJKU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

Extension of the Termination Date

 

An aggregate of $34,330.96 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, representing the lesser of (i) $80,000 for all outstanding public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from August 6, 2026 to September 6, 2026 (the “Termination Date”). The Extension is the 21st extension permitted under the Amended and Restated Articles of Association of the Company currently in effect.

 

Promissory Note

 

In connection with the Extension, the Company issued, on August 6, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”) to Aimei Health Ltd, a Cayman Islands exempted company (the “Payee”), to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payee has the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notice of its intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

 

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Promissory Note, dated August 6, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 6, 2026

 

  Aimei Health Technology Co., Ltd
     
  By: /s/ Junheng Xie
  Name: Junheng Xie
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)

 

 

 

Filing Exhibits & Attachments

5 documents